Revill P.AChisari F.VBlock J.MDandri MGehring A.JGuo HHu JKramvis ALampertico PJanssen H.L.ALevrero MLi WLiang T.JLim S.-GLu FPenicaud M.CTavis J.EThimme RArbuthnot PBoonstra AChang K.-MPEI-JER CHENGlebe DGuidotti L.GFellay JFerrari CJansen LLau D.T.YLok A.SMaini M.KMason WMatthews GParaskevis DPetersen JRehermann BShin E.-CThompson Avan Bömmell FWang F.-SWatashi KHUNG-CHIH YANGYuan ZYuen M.-FBlock TMiller VProtzer UBréchot CLocarnini SPeters M.GSchinazi R.FZoulim FMembers of the ICE-HBV Working Groups, ICE-HBV Stakeholders Group Chairs, ICE-HBV Senior AdvisorsICE-HBV Stakeholders Group Chairs, ICE-HBV Senior AdvisorsMembers of the ICE-HBV Working Groups2021-07-122021-07-1220192468-1253https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066415366&doi=10.1016%2fS2468-1253%2819%2930119-0&partnerID=40&md5=eb1ec42cd8ac4e3e5ad4de448ca64dcdhttps://scholars.lib.ntu.edu.tw/handle/123456789/570839[SDGs]SDG3A global scientific strategy to cure hepatitis Bnote10.1016/S2468-1253(19)30119-0309816862-s2.0-85066415366